New data science-driven alert framework expected to reduce clinician burden by 45% while preserving industry-leading ...

Netflix’s bet on a theatrical release for the “Stranger Things” series finale is looking like it will pay off, at least according to AMC Theatres CEO Adam Aron, who teased that the theater chain would ...

AMC has shared a new teaser and first look images for Season 4 of the noir thriller Dark Winds starring executive producer Zahn McClarnon (The Son, Westworld, Fargo). Consisting of eight hour-long ...

The original “Avatar” film was released in 2009, with a $77 million domestic opening weekend before going on to gross $2.92 billion worldwide— a record at the time and still the franchise’s all-time ...

If you've just finished Season 3 of Dark Winds, you're probably already excited for Season 4. The AMC series is based on the "Leaphorn & Chee" novels by bestselling author Tony Hillerman. Set in the ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced ...

Measuring change in bone mineral density, rather than fracture occurrence, promises to speed development of new drugs to treat osteoporosis. FNIH Biomarkers Consortium collaborated with the National ...

The proposal would have required recipients to get treatment for addiction or mental illness as a condition of receiving housing funds. The administration has said it will try again. By Jason DeParle ...

A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.